Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Background Randomised controlled trials are considered the gold standard for testing the
efficacy of novel therapeutic interventions, and typically report the average treatment effect …

Background There are limited data from randomized trials to guide a specific follow-up
surveillance approach after myocardial revascularization. Whether a follow-up strategy that …

Background Numerous definitions for peri-procedural myocardial infarction (PMI) following
percutaneous coronary intervention (PCI) and coronary bypass grafting (CABG) surgery …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Current
pharmacological interventions for the CVDs suffer from low bioavailability, low retention rate …

Task Force structure and summary of clinical evidence of 2022 ESC/EACTS review of the
2018 guideline recommendations on the revascularization of left main coronary artery …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …